Arrowhead Pharmaceuticals Inc (ARWR) is a biotechnology company listed on US.
Latest reported ARWR revenue for 2025-09-30 was $829.4M. Net income was $30.1M. Revenue was up 23258.2% from 2024-09-30 to 2025-09-30. ARWR currently screens at market cap $10.59B.
Use this ARWR page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the ARWR quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the ARWR SEC filings page. Lician reads the product cache first so this HTML stays unique to Arrowhead Pharmaceuticals Inc even when a live quote feed is slow.
Latest cached year on this hub. Full ARWR income, balance, and cash tables.